FPIs withdraw record ₹94,000 crore from Indian equities in October on attractive Chinese valuations
The Hindu
October saw record ₹94,000 crore outflow from Indian stock market due to high valuations, shifting focus to Chinese equities.
Foreign investors pulled out a massive ₹94,000 crore (around USD 11.2 billion) from the Indian stock market in October, making it the worst-ever month in terms of outflows, triggered by the elevated valuation of domestic equities and attractive valuations of Chinese stocks.
Before this, foreign portfolio investors (FPIs) withdrew ₹61,973 crore from equities in March 2020. The latest outflow came after a nine-month high investment of ₹57,724 crore in September 2024.
Since June 2024, FPIs have consistently bought equities after withdrawing ₹34,252 crore in April-May. Overall, FPIs have been net buyers in 2024, except for January, April and May, data with the depositories showed.
“Looking ahead, the trajectory of global events like geopolitical developments, interest rate movements, progress in the Chinese economy and the outcome of the U.S. presidential election will play a crucial role in shaping future foreign investment in Indian equities,” Himanshu Srivastava, Associate Director, Manager Research, Morningstar Investment Research India, said.
“On the domestic front, key indicators like inflation trajectory, corporate earnings, and the impact of festive season demand will also be closely watched by FPIs as they assess opportunities in the Indian market,” he added.
According to the data, FPIs recorded a net outflow of ₹94,017 crore in October. The intensity of net outflows could be gauged from the fact that except for one day, FPIs were net sellers throughout the month, bringing their total investment for 2024 down to ₹6,593 crore.
This relentless selling resulted in about an 8% decline in benchmark indices from their peaks.
Rupee hits all-time low at 85.20 against USD due to strong greenback, rising crude oil prices, and weak domestic markets.
Viatris faces U.S. FDA import alert for products from Indore plant, exceptions made for certain shortages.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.
China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.
India's controversial popcorn tax system sparks outrage and criticism, with opposition questioning the complex GST rates.
ICAI President investigates auditing lapses at Byju's, disciplinary committee probing, details undisclosed, part of ongoing investigations.
Sensex and Nifty rebound sharply after steep decline, driven by value buying, bluechip stocks, and global market rally.
AS-IT-IS Nutrition aims for ₹300 crore GMV in 2025 with ATOM range, endorsed by Ravindra Jadeja.